Suppr超能文献

地塞米松对择期腹腔镜胆囊切除术患者术后症状的影响:随机临床试验。

Effect of dexamethasone on postoperative symptoms in patients undergoing elective laparoscopic cholecystectomy: randomized clinical trial.

机构信息

Department of Anesthesiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco, Mexico.

出版信息

World J Surg. 2010 May;34(5):895-900. doi: 10.1007/s00268-010-0457-9.

Abstract

BACKGROUND

Dexamethasone has been reported to reduce postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy (LC). However, its effects on other surgical outcomes, such as pain and fatigue, have been unclear. We evaluated the efficacy of preoperative dexamethasone for ameliorating postoperative symptoms after LC.

METHODS

In this prospective, double-blind, placebo-controlled study, 210 patients scheduled for elective LC were analyzed after randomization to intravenous dexamethasone (8 mg) or a placebo. All patients underwent standardized procedures for general anesthesia and surgery. Episodes of PONV and the pain and fatigue scores were recorded on a visual analog scale. Analgesic and antiemetic requirements were also recorded.

RESULTS

There were no significant differences between groups with regard to medical or demographic variables. Significantly fewer patients experienced PONV in the dexamethasone group immediately after LC and at 6 and 12 h. The need for ondansetron to relieve PONV was higher in the placebo group (P = 0.001). Patients in the study group reported less postoperative pain during the first 24 h and less fatigue after 6, 12, and 24 h. The need for buprenorphine to relieve intolerable pain was also less in this group (P = 0.009). There were no side effects, and the morbidity was similar in the two groups (6.7 vs. 7.6%).

CONCLUSIONS

The regimen we employed is safe and without apparent side effects. Thus, preoperative dexamethasone can significantly reduce the incidence of PONV, pain and fatigue after elective LC.

摘要

背景

地塞米松已被报道可减少腹腔镜胆囊切除术(LC)后的术后恶心和呕吐(PONV)。然而,其对其他手术结果(如疼痛和疲劳)的影响尚不清楚。我们评估了术前地塞米松改善 LC 后术后症状的疗效。

方法

在这项前瞻性、双盲、安慰剂对照研究中,对 210 名计划接受择期 LC 的患者进行了分析,这些患者在随机分组后接受静脉注射地塞米松(8mg)或安慰剂。所有患者均接受了全身麻醉和手术的标准化程序。PONV 发作次数、疼痛和疲劳评分均采用视觉模拟量表记录。还记录了镇痛和止吐药物的需求。

结果

两组在医疗或人口统计学变量方面无显著差异。LC 后即刻以及 6 小时和 12 小时,地塞米松组发生 PONV 的患者明显较少。需要昂丹司琼缓解 PONV 的患者在安慰剂组中更多(P = 0.001)。研究组患者在第 1 天的前 24 小时报告的术后疼痛较轻,6、12 和 24 小时后的疲劳感较轻。需要丁丙诺啡缓解无法忍受的疼痛的患者在该组中也较少(P = 0.009)。两组均无副作用,发病率相似(6.7%比 7.6%)。

结论

我们采用的方案安全且无明显副作用。因此,术前地塞米松可显著降低择期 LC 后 PONV、疼痛和疲劳的发生率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验